Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-11

Clinical Trial Update: R-Verapamil for the Prophylaxis of Episodic Cluster Headache [Phase 2]

View source ↗

Summary

Phase 2 trial of R-Verapamil for prophylaxis of episodic cluster headache has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R-Verapamil (R-verapamil)

Snippet

Sponsor: Center Laboratories, Inc. | Conditions: Episodic Cluster Headache | Phase 2 | Status: TERMINATED